Eris Lifesciences Q4 Results

  • BSE: 540596
  • NSE: ERIS
  • ISIN: INE406M01024
  • Sector: Biotechnology & Drugs
BSE
1,467.4591.30 (6.63%)
Volume22.18 K
Updated: Mon 25 Nov, 2024 | 15:43:15
NSE
1,473.7599.55 (7.24%)
Volume7.45 L
Updated: Mon 25 Nov, 2024 | 15:43:27
Today: 1,388.00
1,488.10
52-Wk: 810.10
1,521.05

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Eris Lifesciences Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 550.92423.26-%402.80-%
    Selling/ General/ Admin Expenses Total 102.4787.00-%85.81-%
    Depreciation/ Amortization 53.9029.90-%35.13-%
    Other Operating Expenses Total 181.83110.27-%125.34-%
    Total Operating Expense 456.39315.95-%319.03-%
    Operating Income 94.53107.30-%83.76-%
    Net Income Before Taxes 76.65106.54-%75.90-%
    Net Income 70.96101.86-%65.42-%
    Diluted Normalized EPS 5.217.49-%4.79-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts